Ad copy

From the rise of obesity and GLP-1 research to stronger trial success rates and shifting sponsor dynamics, 2025 marked a year of quality over quantity in clinical development. Uncover which therapeutic areas gained momentum, which sponsors led the field and how regulatory, economic and geopolitical forces influenced trial activity worldwide. Download the Annual Completed Clinical Trials Report for a data-driven view of the industry's changing landscape.